Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study

Description

The purpose of this research is to determine whether a 16 week, home-based, aerobic and resistance exercise intervention will increase physical activity levels in Black and Hispanic breast, colorectal, or prostate cancer patients. The names of the study interventions involved in this study are: * Supervised aerobic and resistance exercise (SUP) - virtually supervised 16- week aerobic and resistance exercise performed at home via Zoom. * Unsupervised aerobic and resistance exercise (UNSUP) - home-based 16- week aerobic and resistance exercise. * Attention control (AC) - 16-week home-based stretching.

Conditions

Breast Cancer, Colorectal Cancer, Prostate Cancer

Study Overview

Study Details

Study overview

The purpose of this research is to determine whether a 16 week, home-based, aerobic and resistance exercise intervention will increase physical activity levels in Black and Hispanic breast, colorectal, or prostate cancer patients. The names of the study interventions involved in this study are: * Supervised aerobic and resistance exercise (SUP) - virtually supervised 16- week aerobic and resistance exercise performed at home via Zoom. * Unsupervised aerobic and resistance exercise (UNSUP) - home-based 16- week aerobic and resistance exercise. * Attention control (AC) - 16-week home-based stretching.

Testing Home-based Exercise Strategies to Improve Exercise Participation and Cardiovascular Health in Underserved Minority Patients With Cancer Undergoing Chemotherapy: the THRIVE Study

Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Boston

Brigham and Women's Hospital, Boston, Massachusetts, United States, 02115

Boston

Dana Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Over 18 years old; children under the age of 18 will be excluded due to rarity of disease
  • * Newly diagnosed with stage I-III breast, colorectal or prostate cancer
  • * Self-identify as Hispanic or Black
  • * Are within 4 weeks of initiating chemotherapy
  • * Overweight or obese (BMI \>25kg/m2 or body fat percent \>30)
  • * Physician's clearance to participate in moderate-vigorous intensity exercise
  • * Speak English or Spanish
  • * Engaging in less than 90 minutes of moderate-or-vigorous physical activity per week
  • * Willing to travel to Dana-Farber Cancer Institute for necessary data collection
  • * Ability to understand and the willingness to sign a written informed consent document.
  • * Pre-existing musculoskeletal or cardiorespiratory conditions
  • * Patients should not have any uncontrolled illness including ongoing or active infection, uncontrolled diabetes, hypertension, or thyroid disease
  • * Patients with other active malignancies
  • * Patients with metastatic disease
  • * Participate in more than 90 minutes of structured exercise/week
  • * Unable to travel to Dana-Farber Cancer Institute for necessary data collection
  • * Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dana-Farber Cancer Institute,

Christina Dieli-Conwright, PhD, MPH, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

2025-12-31